Company Information
TWD
162
- (0.3%)
TWSE:1707, GRAPE KING BIO LTD
Industry: Drug Manufacturers - Specialty & Generic
End of Day: 14 June 2024 GMT+8
Grape King Bio Ltd is a specialty and generic drug manufacturing company engaged in the production and sales of pharmaceutical preparation, patent medicine, liquid tonic, drink, and healthy food. The company has three segments: MLM (Multi-Level Marketing) is a direct seller of Pro-partner Inc, including the Company’s development and manufacturing products for Pro-partner Inc, Distributors segment includes the company’s self-owned brand products, and ODM/OEM (Original Design Manufacturer/Original Equipment Manufacturer) includes ODM/OEM in Taiwan and Shanghai. The group operates in three principal geographical areas - Taiwan, China, and Others and it derives a majority of its revenue from Taiwan.
Address
No. 402, Jinling Road
Section 2, Pingzhen District
Website
Classification
Sector
Healthcare
Industry Group
Drug Manufacturers
Industry
Drug Manufacturers - Specialty & Generic
Key Executives
Dr. Sheng-Lin Tseng
Chairman of the Board/Director/General Manager
Ms. Mei-Ching Tseng
Director
Mr. Jue-Jia Chang
Director
Mr. Yen-Shiang Huang
Director
Mr. Chih-Wei Lai
Director
Mr. Chih-Sheng Chang
Director
Ms. Hsing-Chun Chen
Director
Ms. Shiow-Ling Kao
Director
Mr. Feng- I Lin
Director
Dr. Ching-Pu Chen
Director
Ms. I-Fan Miao
Director
Ms. Jing Ning Chen
Director
Ownership
Institution Holdings
Vanguard Group Inc
3,552,212 (2.398%)
BlackRock Fund Advisors
1,686,000 (1.138%)
Dimensional Fund Advisors
864,000 (0.583%)
Dimensional Fund Advisors LP
741,121 (0.500%)
Vanguard Equity Investment Group
733,000 (0.495%)
WisdomTree Asset Management Inc
590,988 (0.399%)
State Street Global Advisors
497,356 (0.336%)
BlackRock Advisors (UK) Limited
357,000 (0.241%)
Quoniam Asset Management GmbH
312,086 (0.211%)
Northern Trust Investments Inc
278,015 (0.188%)
Funds Holdings
DFA Emerging Markets Core Equity Fund
864,000 (0.583%)
Dodge & Cox Emerging Markets Stock Fund
126,714 (0.086%)
BlackRock MSCI ACWI ex-U.S. IMI Index NL
118,110 (0.080%)
State Street Gbl All Cap Equity ExUS NL
114,476 (0.077%)
BlackRock MSCI ACWI ex-U.S. IMI Index
110,541 (0.075%)
NT ACWI ex US IMI Fund - NL
84,187 (0.057%)
NT ACWI ex-US IMI Fd - DC - NL
46,376 (0.031%)
Dimensional Emerging Mkts Core Eqty
44,000 (0.030%)
DFA Emerging Mkts ex China Cr Eq Port
38,000 (0.026%)
Franklin Templeton SinoAm TW Smart ETF
28,166 (0.019%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
